Concepedia

Giorgio Bonanomi

GB

11

Publications

405

Citations

11

H-Index

1996

Active since

Affiliations

GlaxoSmithKline (Italy)(Current)

GlaxoSmithKline (United Kingdom)

Harlow College

Reckitt Benckiser (United States)

St. John's University

Giorgio Bonanomi is an author at GlaxoSmithKline (Italy) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1996–2010

11

Publications

11

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines:  A Series of Potent and Selective Dopamine D<sub>3</sub>Receptor Antagonists

Fabrizio Micheli, Giorgio Bonanomi, Frank E. Blaney et al. · Journal of Medicinal Chemistry · 2007 · 83 citations · Full text

6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

Fabrizio Micheli, Paolo Cavanni, Daniele Andreotti et al. · Journal of Medicinal Chemistry · 2010 · 68 citations · Full text

, , +16

1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D<sub>3</sub>Receptor Antagonists

Fabrizio Micheli, Luca Arista, Giorgio Bonanomi et al. · Journal of Medicinal Chemistry · 2009 · 55 citations · Full text

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors

Fabrizio Micheli, Paolo Cavanni, Roberto Arban et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

, , +15

Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: Synthesis and biological evaluation

Fabrizio Micheli, Alessandra Pasquarello, Giovanna Tedesco et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 36 citations · Full text

, , +10

Rows per page

1–5 of 11